WHO Identifies Emerging Innovations in Global Health
The WHO Science Division conducted a horizon scan exercise to identify new and emerging innovations in science and technology that could significantly impact global health in the future. The article invites readers to consider the innovations from a public health perspective and to assess their potential benefits and risks.
Recent Posts
Rapid Genetic Testing Mitigates Gentamicin-Induced Hearing Loss in Neonates
Rapid genetic testing is dramatically improving neonatal care by detecting the m.1555A>G mitochondrial variant in newborns at risk of profound hearing loss from gentamicin, allowing swift switches to alternative antibiotics without delaying treatment. Developed through the
EMA’s Clinical Trials Guidance for Enhancing Flexibility During Public Health Emergencies
The European Medicines Agency (EMA) has released draft clinical trials guidance for public consultation from 4 March to 30 April 2026. This guidance outlines regulatory flexibi...
Portugal Clinical Trials Regulation: A Comprehensive Framework for EU Compliance and Participant ...
Portugal Aligns with EU Standards
Portugal clinical trials regulation is now firmly established through Lei n.º 9/2026, published on March 6, 2026, which implements the European Parliament and Council